- Joined
- Sep 19, 2014
- Messages
- 498
- Reaction score
- 3,241
A study at Henry Ford Hospital in Detroit finds that in a strictly monitored protocol-driven in-hospital setting, treatment with hydroxychloroquine alone and hydroxychloroquine + azithromycin was associated with a significant reduction in mortality among patients hospitalized with COVID-19.
The authors of the study conclude that their “findings do support the recent NIH guidelines (Antiviral Therapy, 2020), indicating a potential role for hydroxychloroquine in treatment of hospitalized COVID-19 patients without co-administration of azithromycin,” and that “considered in the context of current studies on the use of hydroxychloroquine for COVID-19, [their] results suggest that hydroxychloroquine may have an important role to play in reducing COVID-19 mortality.
The full study is available for review here:
https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext
The authors of the study conclude that their “findings do support the recent NIH guidelines (Antiviral Therapy, 2020), indicating a potential role for hydroxychloroquine in treatment of hospitalized COVID-19 patients without co-administration of azithromycin,” and that “considered in the context of current studies on the use of hydroxychloroquine for COVID-19, [their] results suggest that hydroxychloroquine may have an important role to play in reducing COVID-19 mortality.
The full study is available for review here:
https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext